急性呼吸窘迫综合征患者动脉二氧化碳管理模式的启示:LUNG SAFE研究
基于LUNG SAFE国际多中心观察性研究,分析2813例早期ARDS患者第1天及持续(第1天和第2天)低碳酸血症、正常碳酸血症和高碳酸血症的患病率及其对通气和结局的影响。结果显示持续低碳酸血症在轻中度ARDS中与更高的ICU死亡率相关,而未发现高碳酸血症的获益或危害证据。
要点
- 早期ARDS中高碳酸血症常见(43.2%),持续高碳酸血症患者接受更多保护性通气。
- 持续低碳酸血症在轻中度ARDS患者中与ICU死亡率升高相关(38.1% vs 27.1%)。
- 动脉CO2水平与结局无独立关联,倾向性匹配分析中持续正常碳酸血症与高碳酸血症的住院死亡率均为36%。
核心结论
- 未发现高碳酸血症对早期ARDS患者有获益或危害的证据。
- 持续低碳酸血症在轻中度ARDS患者中与更高的ICU死亡率相关,值得关注。
研究设计与样本
- 国际多中心观察性研究(LUNG SAFE),纳入2813例早期ARDS患者。
- 主要目的为调查第1天及持续(第1天和第2天)低碳酸血症(PaCO2 < 35 mm Hg)、正常碳酸血症(PaCO2 35-45 mm Hg)和高碳酸血症(PaCO2 > 45 mm Hg)的患病率。
主要发现
- 第1天低碳酸血症551例(19.6%;95%CI 18.1-21.1),正常碳酸血症1018例(36.2%;95%CI 34.4-38.0),高碳酸血症1214例(43.2%;95%CI 41.3-45.0)。
- 持续低碳酸血症252例(9.3%;95%CI 8.2-10.4),持续正常碳酸血症544例(19.3%;95%CI 17.9-20.8),持续高碳酸血症654例(24.1%;95%CI 22.5-25.7)。
- 低碳酸血症在接受无创通气的患者中更常见且更严重,但在控制性机械通气患者中也有观察到。
- 持续低碳酸血症在中收入国家更常见,持续高碳酸血症在欧洲更常见。
- 持续高碳酸血症患者ARDS严重程度最高,且接受更多保护性通气。
关键数值与推荐
- 低碳酸血症定义为PaCO2 < 35 mm Hg,正常碳酸血症为PaCO2 35-45 mm Hg,高碳酸血症为PaCO2 > 45 mm Hg。
- 倾向性匹配分析中,持续正常碳酸血症与持续高碳酸血症患者的住院死亡率均为36%(P = 1.0)。
- 轻中度ARDS患者中,持续低碳酸血症者ICU死亡率为38.1%,正常碳酸血症者为27.1%。
临床怎么用
- 在早期ARDS管理中对动脉CO2水平应予以关注,尤其是避免持续低碳酸血症,特别是在轻中度ARDS患者中。
- 高碳酸血症在早期ARDS中常见,但未发现其独立增加死亡风险,允许性高碳酸血症策略可能无需过度担忧。
局限性
- 本研究为观察性研究,无法确定因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Considerable variability exists regarding CO2 management in early ARDS, with the impact of arterial CO2 tension on management and outcomes poorly understood. RESEARCH QUESTION: To determine the prevalence and impact of hypocapnia and hypercapnia on the management and outcomes of patients with early ARDS enrolled in the Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE) study, an international multicenter observational study. STUDY DESIGN AND METHODS: Our primary objective was to examine the prevalence of day 1 and sustained (day 1 and 2) hypocapnia (Paco2 < 35 mm Hg), normocapnia (Paco2 35-45 mm Hg), and hypercapnia (Paco2 > 45 mm Hg) in patients with ARDS. Secondary objectives included elucidating the effect of CO2 tension on ventilatory management and examining the relationship with ARDS outcome. RESULTS: Of 2,813 patients analyzed, 551 (19.6%; 95%CI, 18.1-21.1) were hypocapnic, 1,018 (36.2%; 95% CI, 34.4-38.0) were normocapnic, and 1,214 (43.2%; 95% CI, 41.3-45.0) were hypercapnic, on day 1. Sustained hypocapnia was seen in 252 (9.3%; 95% CI, 8.2-10.4), sustained normocapnia in 544 (19.3%; 95% CI, 17.9-20.8), and sustained hypercapnia in 654 (24.1%; 95% CI, 22.5-25.7) patients. Hypocapnia was more frequent and severe in patients receiving noninvasive ventilation but also was observed in patients on controlled mechanical ventilation. Sustained hypocapnia was more frequent in middle-income countries, whereas sustained hypercapnia was more frequent in Europe. ARDS severity profile was highest in sustained hypercapnia, and these patients received more protective ventilation. No independent association was seen between arterial CO2 and outcome. In propensity-matched analyses, the hospital mortality rate was 36% in both sustained normocapnic and hypercapnic patients (P = 1.0). ICU mortality was higher in patients with mild to moderate ARDS receiving sustained hypocapnia (38.1%) compared with normocapnia (27.1%). INTERPRETATION: No evidence was found for benefit or harm with hypercapnia. Of concern, ICU mortality was higher with sustained hypocapnia in mild to moderate ARDS.
引用
- Madotto F, Rezoagli E, McNicholas BA, et al. Patterns and Impact of Arterial CO2 Management in Patients With Acute Respiratory Distress Syndrome: Insights From the LUNG SAFE Study. Chest. 2020. PMID: 32589951. doi:10.1016/j.chest.2020.05.605
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。